Boston Jury Awards $42.6 Million to Man in Landmark Mesothelioma Case Against Johnson & Johnson
BOSTON — A jury has awarded a Massachusetts man $42.6 million after finding that Johnson & Johnson was liable for his diagnosis of mesothelioma, a rare and aggressive cancer often linked to asbestos exposure. The decision highlights ongoing concerns about the use of asbestos in consumer products, particularly talc-based powders. In the trial, which concluded this week, the plaintiff, identified as Stephen Lanzo III, argued that his illness stemmed from long-term exposure to Johnson & Johnson’s talc products, which he claimed were contaminated with asbestos. The jury’s verdict reflects the belief that the company failed … Read more